1. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trial Group Study 5087;Aberg;AIDS Research and Human Retroviruses,2005
2. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens;Anastos;Journal of Acquired Immune Deficiency Syndromes,2007
3. Aslangul, E., Assoumou, K., Bittar, R., Valatin, M., Klamykova, O., Peytavin, M., … Costagliola, D. (2007, October). A prospective, randomized open label trial comparing the efficacy and safety of rosuvastatin versus pravastatin in HIV-infected subjects receiving ritonavir boosted PI with lipid abnormalities. Poster session presented at the 11th European AIDS Conference, Madrid, Spain.
4. The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: Shifting paradigms;Baker;Current Opinion in HIV & AIDS,2009